Effects of Rifaximin on Central Responses to Social Stress—a Pilot Experiment

Neurotherapeutics

Volumn 15, Issue 3, 2018, Pages 807-818

  Wang, Huiying ^a,b   Braun, Christoph ^a,c   Enck, Paul ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Graduate Training Centre of Neuroscience   (Germany)

^c UNIVERSITY OF TRENTO   (Italy)

Author keywords

Antibiotic; Cyberball; Gut brain axis; MEG; Stress

Indexed keywords

PLACEBO; RIFAXIMIN; ANTIINFECTIVE AGENT; GASTROINTESTINAL AGENT;

ADULT; ANTERIOR CINGULATE; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; MAGNETOENCEPHALOGRAPHY; MALE; MOOD; NERVE POTENTIAL; NORMAL HUMAN; PERCEPTION; PILOT STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL EXCLUSION; SOCIAL STRESS; DIAGNOSTIC IMAGING; DRUG THERAPY; ELECTROENCEPHALOGRAM; EXERCISE; GAME; MENTAL STRESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; REST;

ADULT; ANTI-BACTERIAL AGENTS; BRAIN WAVES; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; GAMES, EXPERIMENTAL; GASTROINTESTINAL AGENTS; HEALTHY VOLUNTEERS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; MALE; REST; RIFAXIMIN; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES;

EID: 85051622977     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-018-0627-2     Document Type: Article

References (66)

1. Hyland NP, Cryan JF. Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system. Dev Biol. 2016;417(2):182–187.
2. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012;13(10):701–712.
3. Cryan JF, O’Mahony SM. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil. 2011;23(3):187–192.
4. Cryan JF, Dinan TG. More than a gut feeling: the microbiota regulates neurodevelopment and behavior. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2015;40(1):241–2.
5. Cox LM, Weiner HL. Microbiota Signaling Pathways that Influence Neurologic Disease. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics. 2018;15(1):135–45.
6. Proctor C, Thiennimitr P, Chattipakorn N, Chattipakorn SC. Diet, gut microbiota and cognition. Metab Brain Dis. 2017;32(1):1–17.
7. Gareau MG. Microbiota-gut-brain axis and cognitive function. Adv Exp Med Biol. 2014;817:357–371.
8. O’Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, et al. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience. 2014;277:885–901.
9. Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. Microbiota is essential for social development in the mouse. Molecular Psychiatry. 2014;19(2):146–148.
10. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004;558(Pt 1):263–275.
11. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;23(3):255–264, e119.
12. Wang T, Hu X, Liang S, Li W, Wu X, Wang L, et al. Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes. 2015;6(5):707–717.
13. Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M, et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2017;66(4):806–815.
14. Wang H, Lee IS, Braun C, Enck P. Effect of probiotics on central nervous system functions in animals and humans—a systematic review. J Neurogastroenterol Motil. 2016.
15. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451–1463.
16. Kantak PA, Bobrow DN, Nyby JG. Obsessive-compulsive-like behaviors in house mice are attenuated by a probiotic (Lactobacillus rhamnosus GG). Behav Pharmacol. 2014;25(1):71–79.
17. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011;108(38):16050–16055.
18. Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, et al. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 2017;153(2):448–459 e8.
19. DuPont HL. Biologic properties and clinical uses of rifaximin. Expert Opin Pharmacother. 2011;12(2):293–302.
20. DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers’ diarrhea. Ann Intern Med. 2005;142(10):805–812.
21. Pimentel M, Morales W, Chua K, Barlow G, Weitsman S, Kim G, et al. Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects. Dig Dis Sci. 2011;56(7):2067–2072.
22. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med. 2006;145(8):557–563.
23. Gatta L, Scarpignato C. Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Aliment Pharmacol Ther. 2017;45(5):604–616.
24. Scarpellini E, Gabrielli M, Lauritano CE, Lupascu A, Merra G, Cammarota G, et al. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2007;25(7):781–786.
25. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG. Effects of the Probiotic Bifidobacterium Infantis in the Maternal Separation Model of Depression. Neuroscience. 2010;170(4):1179–1188.
26. Savignac HM, Kiely B, Dinan TG, Cryan JF. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil. 2014;26(11):1615–1627.
27. Williams KD, Jarvis B. Cyberball: a program for use in research on interpersonal ostracism and acceptance. Behavior Research Methods. 2006;38(1):174–180.
28. Allen AP, Kennedy PJ, Cryan JF, Dinan TG, Clarke G. Biological and psychological markers of stress in humans: focus on the Trier Social Stress Test. Neurosci Biobehav Rev. 2014;38:94–124.
29. McQuaid RJ, McInnis OA, Matheson K, Anisman H. Distress of ostracism: oxytocin receptor gene polymorphism confers sensitivity to social exclusion. Soc Cogn Affect Neurosci. 2015;10(8):1153–1159.
30. Beekman JB, Stock ML, Marcus T. Need to Belong, Not Rejection Sensitivity, Moderates Cortisol Response, Self-Reported Stress, and Negative Affect Following Social Exclusion. J Soc Psychol. 2016;156(2):131–138.
31. Blackhart GC, Eckel LA, Tice DM. Salivary cortisol in response to acute social rejection and acceptance by peers. Biol Psychol. 2007;75(3):267–276.
32. Stroud LR, Salovey P, Epel ES. Sex differences in stress responses: social rejection versus achievement stress. Biol Psychiatry. 2002;52(4):318–327.
33. Kelly M, McDonald S, Rushby J. All alone with sweaty palms—physiological arousal and ostracism. International journal of psychophysiology: official journal of the International Organization of Psychophysiology. 2012;83(3):309–314.
34. Paolini D, Alparone FR, Cardone D, van Beest I, Merla A. “The face of ostracism”: The impact of the social categorization on the thermal facial responses of the target and the observer. Acta Psychologica. 2016;163:65–73.
35. Wang H, Braun C, Enck P. How the brain reacts to social stress (exclusion)—A scoping review. Neurosci Biobehav Rev. 2017;80:80–88.
36. Bolling DZ, Pelphrey KA, Vander Wyk BC. Unlike adults, children and adolescents show predominantly increased neural activation to social exclusion by members of the opposite gender. Soc Neurosci. 2016;11(5):475–486.
37. Eisenberger NI, Taylor SE, Gable SL, Hilmert CJ, Lieberman MD. Neural pathways link social support to attenuated neuroendocrine stress responses. Neuroimage. 2007;35(4):1601–1612.
38. Maurage P, Joassin F, Philippot P, Heeren A, Vermeulen N, Mahau P, et al. Disrupted regulation of social exclusion in alcohol-dependence: an fMRI study. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2012;37(9):2067–2075.
39. Cristofori I, Harquel S, Isnard J, Mauguiere F, Sirigu A. Monetary reward suppresses anterior insula activity during social pain. Soc Cogn Affect Neurosci. 2015;10(12):1668–1676.
40. Kawamoto T, Nittono H, Ura M. Cognitive, Affective, and Motivational Changes during Ostracism: An ERP, EMG, and EEG Study Using a Computerized Cyberball Task. Neuroscience Journal. 2013;2013:304674.
41. van Noordt SJ, White LO, Wu J, Mayes LC, Crowley MJ. Social exclusion modulates event-related frontal theta and tracks ostracism distress in children. Neuroimage. 2015;118:248–255.
42. Cohen D. Magnetoencephalography: detection of the brain's electrical activity with a superconducting magnetometer. Science (New York, NY). 1972;175(4022):664–666.
43. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
44. Sebastian C, Viding E, Williams KD, Blakemore SJ. Social brain development and the affective consequences of ostracism in adolescence. Brain Cogn. 2010;72(1):134–145.
45. Oostenveld R, Fries P, Maris E, Schoffelen JM. FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci. 2011;2011:156869.
46. Gross J, Kujala J, Hamalainen M, Timmermann L, Schnitzler A, Salmelin R. Dynamic imaging of coherent sources: Studying neural interactions in the human brain. Proc Natl Acad Sci U S A. 2001;98(2):694–699.
47. Bolling DZ, Pitskel NB, Deen B, Crowley MJ, Mayes LC, Pelphrey KA. Development of neural systems for processing social exclusion from childhood to adolescence. Dev Sci. 2011;14(6):1431–1444.
48. Romijn AR, Rucklidge JJ. Systematic review of evidence to support the theory of psychobiotics. Nutr Rev. 2015;73(10):675–693.
49. Mazurak N, Broelz E, Storr M, Enck P. Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? J Neurogastroenterol Motil. 2015;21(4):471–485.
50. Ford AC, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109(10):1547–1561; quiz 6, 62.
51. Ahluwalia V, Wade JB, Heuman DM, Hammeke TA, Sanyal AJ, Sterling RK, et al. Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axis. Metab Brain Dis. 2014;29(4):1017–1025.
52. Bajaj JS, Heuman DM, Sanyal AJ, Hylemon PB, Sterling RK, Stravitz RT, et al. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One. 2013;8(4):e60042.
53. Nunez PL, Wingeier BM, Silberstein RB. Spatial-temporal structures of human alpha rhythms: theory, microcurrent sources, multiscale measurements, and global binding of local networks. Hum Brain Mapp. 2001;13(3):125–164.
54. Fachner J, Gold C, Erkkila J. Music therapy modulates fronto-temporal activity in rest-EEG in depressed clients. Brain Topogr. 2013;26(2):338–354.
55. Tanaka M, Ishii A, Watanabe Y. Neural effects of mental fatigue caused by continuous attention load: a magnetoencephalography study. Brain Res. 2014;1561:60–66.
56. Baumeister J, Barthel T, Geiss KR, Weiss M. Influence of phosphatidylserine on cognitive performance and cortical activity after induced stress. Nutr Neurosci. 2008;11(3):103–110.
57. Diego MA, Field T, Sanders C, Hernandez-Reif M. Massage therapy of moderate and light pressure and vibrator effects on EEG and heart rate. Int J Neurosci. 2004;114(1):31–44.
58. Field T, Ironson G, Scafidi F, Nawrocki T, Goncalves A, Burman I, et al. Massage therapy reduces anxiety and enhances EEG pattern of alertness and math computations. Int J Neurosci. 1996;86(3–4):197–205.
59. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology. 2013;144(7):1394–1401, 401 e1–4.
60. Arnsten AF, Rubia K. Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders. J Am Acad Child Adolesc Psychiatry. 2012;51(4):356–367.
61. Eack SM, Wojtalik JA, Barb SM, Newhill CE, Keshavan MS, Phillips ML. Fronto-Limbic Brain Dysfunction during the Regulation of Emotion in Schizophrenia. PLoS One. 2016;11(3):e0149297.
62. Maccaferri S, Vitali B, Klinder A, Kolida S, Ndagijimana M, Laghi L, et al. Rifaximin modulates the colonic microbiota of patients with Crohn’s disease: an in vitro approach using a continuous culture colonic model system. J Antimicrob Chemother. 2010;65(12):2556–2565.
63. Ponziani FR, Scaldaferri F, Petito V, Paroni Sterbini F, Pecere S, Lopetuso LR, et al. The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin. Dig Dis. 2016;34(3):269–278.
64. Xu D, Gao J, Gillilland M, 3rd, Wu X, Song I, Kao JY, et al. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology. 2014;146(2):484–496 e4.
65. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43(2):164–174.
66. Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol. 2017;14(3):143–159.